Investing.com - Financial Markets Worldwide
Get 40% Off
Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

Japan stocks hover near 29-yr high on vaccine progress, stimulus hopes

Published 03/12/2020, 03:36
Updated 03/12/2020, 03:42
© Reuters.

By Stanley White
TOKYO, Dec 3 (Reuters) - Japan shares inched up to more than
a 29-year high on Thursday as major countries moved closer to
rolling out coronavirus vaccines, while hopes of more stimulus
also boosted sentiment.
The Nikkei 225 Index .N225 rose 0.03% to 26,808.25 by 0204
GMT, near an April 1991 high hit in the previous session, while
the broader Topix .TOPX rose 0.3% to 1,779.27.
Real estate, consumer cyclicals, industrial companies, and
financials rose in a sign that investors are betting on sectors
that will benefit most from a revival in economic growth.
Britain on Wednesday became the first western country to
approve Pfizer Inc's PFE.N COVID-19 vaccine and said it would
start immunization early next week, while U.S. authorities plan
to begin vaccinations by mid-December. In addition, Japan's government has committed to more fiscal
spending and U.S. President-elect Joe Biden has pledged to act
swiftly on economic stimulus measures. "There are reflationary elements in the global economy that
will benefit Japanese equities," said Masayuki Kichikawa, chief
macro strategist at Sumitomo Mitsui Asset Management Co.
"But we need to continue to hear good news about the vaccine
and see no policy mistakes."
The stocks that gained the most among the top 30 core Topix
names were Central Japan Railway Co 9022.T up 3.3 %, followed
by Mitsui & Co Ltd 8031.T , which rose 2.13%.
The underperformers among the Topix 30 were Hoya Corp
7741.T down 3.82%, followed by Daikin Industries Ltd 6367.T
losing 2.28%.
There were 154 advancers on the Nikkei index against 68
decliners.
The volume of shares traded on the Tokyo Stock Exchange's
main board .TOPX was 0.51 billion, compared to the average of
1.3 billion in the past 30 days.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.